Kurt A. Gustafson
2017 - Spectrum Pharmaceuticals
In 2017, Kurt A. Gustafson earned a total compensation of $1.9M as Executive Vice President and Chief Financial Officer at Spectrum Pharmaceuticals, a 80% increase compared to previous year.
Compensation breakdown
Bonus | $237,500 |
---|---|
Option Awards | $343,300 |
Salary | $500,000 |
Stock Awards | $661,213 |
Other | $124,965 |
Total | $1,866,978 |
Gustafson received $661.2K in stock awards, accounting for 35% of the total pay in 2017.
Gustafson also received $237.5K in bonus, $343.3K in option awards, $500K in salary and $125K in other compensation.
Rankings
In 2017, Kurt A. Gustafson's compensation ranked 5,839th out of 14,666 executives tracked by ExecPay. In other words, Gustafson earned more than 60.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,839 | 60th |
Manufacturing | 2,126 | 63rd |
Chemicals And Allied Products | 663 | 68th |
Drugs | 512 | 70th |
Pharmaceutical Preparations | 406 | 70th |
Gustafson's colleagues
We found three more compensation records of executives who worked with Kurt A. Gustafson at Spectrum Pharmaceuticals in 2017.
News
OmniAb CEO Matthew Foehr's 2023 pay falls 60% to $2.6M
April 26, 2024
OmniAb CEO Matthew Foehr's 2022 pay jumps 26% to $6.7M
May 1, 2023
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2021 pay jumps 110% to $7.8M
April 27, 2022
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2019 pay jumps 21% to $5.7M
April 22, 2020
Spectrum Pharmaceuticals COO Thomas Riga's 2018 pay jumps 388% to $5.3M
April 23, 2019